Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.

• Download SqueezeTrigger (TM) Report
• Download FrictionFactor Report
• Download Daily Short Volume Report
• Download Real-Time Short Volume Tool
• Download Failures to Deliver

• [09/05/2025 10:29 PDT] Exicure, Inc. (NASDAQ:XCUR), Down By 100% ($6.65) From $6.65 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [08/27/2025 12:42 PDT] Exicure, Inc. (NASDAQ:XCUR), Down By 100% ($7.15) From $7.15 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bearish Conditions
• [08/18/2025 07:13 PDT] XCUR Expected to Trade Down After Bearish Patterns Develop
• [08/14/2025 07:18 PDT] XCUR Expected to Trade Down Short Term
• [07/30/2025 07:15 PDT] XCUR Expected to Trade Down After Bearish Patterns Develop
• [07/28/2025 07:24 PDT] XCUR Expected to Trade Down Short Term
• [07/24/2025 07:15 PDT] XCUR Expected to Trade Down After Bearish Patterns Develop
• [07/23/2025 07:09 PDT] XCUR Expected to Trade Down Short Term